Drug Trials in Dementia: Challenging Ethical Dilemmas
Journal:
Current Alzheimer Research
Volume:
4
Page:
468-472
Author(s):
Amos D. Korczyn
Editorial [ Neuropeptide Y Receptors as Targets in Drug Discovery Guest Editor: Ambikaipakan Balasubramaniam ]
Journal:
Current Topics in Medicinal Chemistry
Volume:
7
Page:
1644-1644
Author(s):
Ambikaipakan Balasubramaniam
Clinical Potential of Neuropeptide Y Receptor Ligands in the Treatment of Epilepsy
Journal:
Current Topics in Medicinal Chemistry
Volume:
7
Page:
1660-1674
Author(s):
Alfred Meurs, Ralph Clinckers, Guy Ebinger, Yvette Michotte and Ilse Smolders
Recent Developments of the PET Imaging Agents for Metabotropic Glutamate Receptor Subtype 5
Journal:
Current Topics in Medicinal Chemistry
Volume:
7
Page:
1800-1805
Author(s):
Meixiang Yu
Cooling the Injured Brain: How Does Moderate Hypothermia Influence the Pathophysiology of Traumatic Brain Injury
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2310-2322
Author(s):
Juan Sahuquillo and Anna Vilalta
Editorial[Hot Topic:Membrane Channels as Therapeutic Targets (Executive Editor: Jean-Claude Herve)]
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2323-2324
Author(s):
Jean-Claude Herve
Automated Electrophysiology in Drug Discovery
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2325-2337
Author(s):
B.T. Priest, A.M. Swensen and O.B. McManus
Molecular Regulation and Pharmacology of Pacemaker Channels
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2338-2349
Author(s):
Patrick Bois, Romain Guinamard, Antoun E.L. Chemaly, Jean-Francois Faivre and Jocelyn Bescond
Purine Ionotropic (P2X) Receptors
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2368-2384
Author(s):
L. Koles, S. Furst and P. Illes
Pharmacology of Voltage-Gated Proton Channels
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2406-2420
Author(s):
Thomas E. DeCoursey and Vladimir V. Cherny